Nepafenac

From Self-sufficiency
Jump to: navigation, search
Nepafenac
File:Nepafenac-2D-skeletal.png
Systematic (IUPAC) name
2-amino-3-benzoylbenzeneacetamide
Clinical data
Pregnancy
category
  • C
Routes of
administration		 Ophthalmic
Legal status
Legal status
Identifiers
ATC code S01BC10 (WHO)
PubChem CID 151075
Chemical data
Formula C15H14N2O2
Molar mass 254.28 g/mol[[Script error: No such module "String".]]
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Nepafenac is a non-steroidal anti-inflammatory drug (NSAID), usually sold as a prescription eye drop (0.1% solution. Nepafenac is manufactured by Alcon as Nevanac. It is used to treat pain and inflammation associated with cataract surgery.

The usual dose is 1 drop in each affected eye beginning 1 day prior to cataract surgery, continued on the day of surgery and through the first 2 weeks of the postoperative period.

Its side effects may include decreased visual acuity, a feeling that something is in the eye, increased eye pressure or a sticky sensation, as well as other effects.

External links

Non-steroidal anti-inflammatory drug (NSAID) products (primarily M01A and M02A, also N02BA)
Salicylates
Arylalkanoic acids
2-Arylpropionic acids
(profens)
N-Arylanthranilic acids
(fenamic acids)
Pyrazolidine derivatives
Oxicams
COX-2 inhibitors
Sulfonanilides
Topically used products
COX-inhibiting nitric oxide donators
Others
Items listed in bold indicate initially developed compounds of specific groups. †Withdrawn drugs. ‡Veterinary use medications.
Retrieved from "http://ssf.f15ijp.com/wiki/index.php?title=Nepafenac&oldid=40522"